Evidence map›Paper›PMID 35052508›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Dexamethasone Administration in Mice Leads to Less Body Weight Gain over Time, Lower Serum Glucose, and Higher Insulin Levels Independently of NRF2.

Fotini Filippopoulou, George I Habeos, Vagelis Rinotas, Antonia Sophocleous, Gerasimos P Sykiotis, Eleni Douni, Dionysios V Chartoumpekis

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Dexamethasone Inhibits White Adipose Tissue Browning.International journal of molecular sciences · 2024
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Fotini FilippopoulouDivision of Endocrinology, Department of Internal Medicine, School of Medicine, University of Patras, 26504 Patras, Greece.
George I HabeosDivision of Endocrinology, Department of Internal Medicine, School of Medicine, University of Patras, 26504 Patras, Greece.
Vagelis RinotasLaboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, 11855 Athens, Greece.
Antonia SophocleousDepartment of Life Sciences, School of Sciences, European University Cyprus, Nicosia 2404, Cyprus.
Gerasimos P SykiotisService of Endocrinology, Diabetology and Metabolism, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.ORCID 0000-0002-9565-4941
Eleni DouniLaboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, 11855 Athens, Greece.
Dionysios V ChartoumpekisDivision of Endocrinology, Department of Internal Medicine, School of Medicine, University of Patras, 26504 Patras, Greece.ORCID 0000-0002-6139-6067
University of Patras · GRAgricultural University of Athens · GREuropean University Cyprus · CYUniversity of Lausanne · CH

Funding

European Cooperation in Science and Technology CA16112 (NutRedOx).Swiss National Science Foundation IZCOZ0_177070
6 · The paper itself

Abstract

Glucocorticoids are used widely on a long-term basis in autoimmune and inflammatory diseases. Their adverse effects include the development of hyperglycemia and osteoporosis, whose molecular mechanisms have been only partially studied in preclinical models. Both these glucocorticoid-induced pathologies have been shown to be mediated at least in part by oxidative stress. The transcription factor nuclear erythroid factor 2-like 2 (NRF2) is a central regulator of antioxidant and cytoprotective responses. Thus, we hypothesized that NRF2 may play a role in glucocorticoid-induced metabolic disease and osteoporosis. To this end, WT and

Indexed as

antioxidantsdiabetesglucocorticoidsgluconeogenesisinsulin resistanceKEAP1osteoporosis

Identifiers

PMID35052508
PMCPMC8773000
OpenAlexW4200550669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.